2m 2m 2m 2m 2m 2m 2m
SAB BIOTHERAP (SABS)
NASDAQ
$3.09-$0.02 (-0.68%)
Price as of Nov 12, 2026 7:00 AM EST- $280.2MMarket Cap
- -8.80%1-Year Change
- BiotechnologyIndustry
SAB BIOTHERAP (SABS)
$3.09-$0.02 (-0.68%)
SABS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.11 | ||
Change | +$0.04 (+1.30%) | ||
Open | $3.07 | ||
High | $3.23 | ||
Low | $3.06 | ||
Previous Close | $3.07 | ||
Volume | 774,175 | ||
30-Day Average Volume | 629,362 | ||
1-Week Change | -2.20% | ||
1-Month Change | 4.36% | ||
1-Year Change | -8.80% | ||
3-Year Change | -67.95% | ||
5-Year Change | -96.68% | ||
Fundamentals | |||
Shares Outstanding | 90.1M | ||
Total Assets | $235.6M | ||
Market Cap | $280.2M | ||
Enterprise Value | $265.7M | ||
Period: QTR TTM FY | |||
Revenue | $1.6M | ||
Net Income | -$22.3M | ||
Free Cash Flow | -$14.4M | ||
EBIT | -$22.3M | ||
EBITDA | -$21.5M | ||
Net Working Capital | $92.9M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 165 | ||
P/B | 1 | ||
P/E | -13 | ||
PEG | -1 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/05/2024 | ||
Earnings & Revenue